Clinical Trials
390 trialsA Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
GlaxoSmithKline
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
GlaxoSmithKline
ADAPT-OC
Queen's University
PREDICT
Massachusetts General Hospital
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
University of Washington
Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women
Women's Hospital School Of Medicine Zhejiang University
wPap
University of South Dakota
RAINFOL-02
Genmab
TREAT-EC
Rutgers, The State University of New Jersey
V-COSMOS
Cukurova University
ANIHTA
Instituto do Cancer do Estado de São Paulo
CASCADE3002
UNC Lineberger Comprehensive Cancer Center
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
Pfizer
OCRA Distress & Unmet Needs
M.D. Anderson Cancer Center
Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer
Tianjin Medical University Cancer Institute and Hospital
PRIORITY
Pontificia Universidad Catolica de Chile
Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors
Xencor, Inc.
MARACAS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery
Başakşehir Çam & Sakura City Hospital
Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection
Tongji Hospital
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
National Cancer Institute (NCI)
RESO
Zhejiang Cancer Hospital
F-IOTA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
SHAPE-ENDO
Hospital Universitari de Bellvitge
Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy
National Cancer Institute (NCI)
ARTISAN
Peking Union Medical College Hospital
GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education
University of Southern California
MIRA
University of British Columbia
ASCEND
UNC Lineberger Comprehensive Cancer Center
Topical Curcumin for HPV Related Cervical Disease
Emory University
Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV
Emory University
Mail-in HPV Screening Program in NJ
Rutgers, The State University of New Jersey
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
Fred Hutchinson Cancer Center
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
University of California, San Diego
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
Massachusetts General Hospital
RAINFOL™-07
Genmab
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
University of California, San Francisco
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
University of California, Irvine
Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda
Fred Hutchinson Cancer Center
E-FACTOR
Centre Leon Berard
Cancer Awareness Among Syrian Migrants
Toros University
Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer
Shanghai Municipal Hospital of Traditional Chinese Medicine
Social Media-Based Education on Cancer Screening Awareness in Women: A Randomized Controlled Trial
Saglik Bilimleri Universitesi
SIGNAL-EMC 101
Natera, Inc.
A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
HPV Testing as a Prevention of Cervical Dysplasia and Cancer Before Planned Subtotal Hysterectomy
General University Hospital, Prague
The Effect Of Motıvatıonal Intervıewıng On Cancer Fear And Partıcıpatıon In Cervıcal Cancer Screenıngs Among Women Lıvıng In Rural Areas
Akdeniz University Hospital
GORSEM
Marmara University
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.